Generalized principle of designing neutral superstrong Brønsted acids.

J Am Chem Soc

Institute of Chemical Physics, Department of Chemistry, University of Tartu, Jakobi 2, 51014 Tartu, Estonia.

Published: May 2002

A generalized principle of designing superstrong Brønsted acids is suggested according to the following scheme: M=O --> M=Z(X)(n). It consists of the formal replacement of =O fragment in carbonyl, sulfonyl, etc. groups in various acidic systems (e.g., CH(3)CHO, FSO(3)H, where M is the CH(3)CH= or FSO(2)H=fragment, respectively) by =NSO(2)F, =NCN, =C(CN)(2), =P(SO(2)F)(3), =S(CN)(4), or any other formally bivalent group =Z(X)(n) (where the formal valency of the central atom Z is n + 2), leading to highly acidic systems (e.g., HC(=P(CN)(3))NH(2), FS(=C(CN)(2))(2)OH, etc.). It is demonstrated that in several cases the introduction of the double-bonded substituent at the central atom (e.g., N, C, P, S, Cl) that carries the potentially acidic proton or the acidity site (e.g., OH, NH(2), CH(3), etc. groups) will lead to the enormous (up to ca. 120 kcal/mol or 88 pK(a) units!) increase of the intrinsic acidity of the respective parent acid. The acidity of the resulting acids and the scope and limitations of the principle are explored using density functional theory calculations at B3LYP 6-311+G level. Some of the resulting acids (or their anions) were found to undergo fragmentation in the course of the geometry optimization. The general trend that follows from the results of the calculations is that the stability of the resulting compounds is influenced by both the M and the Z. If M is a first row element (carbon or nitrogen), then stable species are produced with almost any Z. If M is a second row element (sulfur or phosphorus), then the species with first row Z are mostly predicted to be stable, but most of the species with second row Z are expected to undergo fragmentation during the geometry optimization. The Z = N and Z = C derivatives (e.g., =NSO(2)CF(3), =C(CN)(2), =C(SO(2)CF(3))(2), etc.) are predicted to be the most stable. However, they have relatively modest electron-accepting power as compared to their penta-, hexa-, and heptavalent counterparts. The acidifying effects of the =Z(X)(n)() groups with the same X increase with increasing n: =NCN < =C(CN)(2) < =P(CN)(3) < =S(CN)(4) and =NSO(2)F < =C(SO(2)F)(2) < =P(SO(2)F)(3). Also, the acidifying effect of a fluorosulfonyl-substituted substituent is higher than that of the corresponding cyano-substituted substituent.

Download full-text PDF

Source
http://dx.doi.org/10.1021/ja0255958DOI Listing

Publication Analysis

Top Keywords

generalized principle
8
principle designing
8
superstrong brønsted
8
brønsted acids
8
acidic systems
8
=ncn =ccn2
8
central atom
8
undergo fragmentation
8
geometry optimization
8
row element
8

Similar Publications

Basic Considerations for Data Pooling Strategy in Multi-Regional Clinical Trials (MRCTs).

Ther Innov Regul Sci

January 2025

Department of Biostatistics, School of Public Health, Peking University, Beijing, China.

The National Medical Products Administration of China has been implementing ICH E17, which describes the general principles for planning and designing of multi-regional clinical trials (MRCTs), yet there are several ambiguities in the execution and conduct remains in China or East Asia. In specific, pooling strategy, effect modifiers (EMs), statistical analysis, sample size allocation and their impact in alignment with global trial remains a challenge. In this paper, we explore on the criteria mentioned above under the context of China.

View Article and Find Full Text PDF

IDO1 inhibits ferroptosis by regulating FTO-mediated m6A methylation and SLC7A11 mRNA stability during glioblastoma progression.

Cell Death Discov

January 2025

State Key Laboratory of Functions and Applications of Medicinal Plants, School of Basic Medical Sciences, Guizhou Provincial Engineering Technology Research Center for Chemical Drug R&D, Guizhou Medical University, Guiyang, China.

Indoleamine 2, 3-dioxygenase 1 (IDO1) has been recognized as an enzyme involved in tryptophan catabolism with immunosuppressive ability. This study determined to investigate the impact of IDO1 on glioblastoma multiforme (GBM) cells. Here, we showed that the expression of IDO1 was markedly increased in patients with glioma and associated with GBM progression.

View Article and Find Full Text PDF

Nanolabels for biosensors based on lateral flow immunoassays.

Anal Chim Acta

February 2025

Department of Physical and Analytical Chemistry & Institute of Biotechnology of Asturias, University of Oviedo, c/Julián Clavería 8, 33006, Oviedo, Spain. Electronic address:

The COVID-19 outbreak was an important turning point in the development of a new generation of biosensing technologies. The synergistic combination of an immunochromatographic test (lateral flow immunoassays, LFIA) and signal transducers provides enhanced sensitivity and the ability to quantify in the rapid tests. This is possible due to the variety of nanoparticles that can be used as reporter labels.

View Article and Find Full Text PDF

LLL 11.1 Organization of nutritional care.

Clin Nutr ESPEN

January 2025

Nutrition Unit, Gustave Roussy Cancer Campus, France.

The increasingly complex health care systems, the large and diverse population to whom nutritional therapy is addressed, and the need of specialized health care professionals implies an organizational strategy to be defined. The organization of nutritional care is a fundamental strategy to promote an optimal, quality and safety nutritional therapy. This is why, the organization of nutritional care should be based on 4 principles, including: Nutritional care should be considered as a process, a multidisciplinary approach is essential to a good nutritional care, the economic approach and the patient centered approach are essential to the organization of nutritional care.

View Article and Find Full Text PDF

Tobramycin nanoformulation for chronic pulmonary infections: From drug product definition to scale-up for preclinical evaluation.

Int J Pharm

January 2025

CIDETEC, Basque Research and Technology Alliance (BRTA), Parque Científico y Tecnológico de Gipuzkoa, Donostia-San Sebastián, Spain; Kusudama Therapeutics SA, Parque Científico y Tecnológico de Gipuzkoa, Donostia-San Sebastián, Spain; Biogipuzkoa Health Research Institute, Group of Innovation, 20014 San Sebastian, Spain.

Cystic fibrosis (CF) is characterized by abnormal mucus hydration due to a defective CF Transmembrane Regulator (CFTR) protein, leading to the production of difficult-to-clear mucus. This causes airflow obstruction, recurrent infections, and respiratory complications. Chronic lung infections are the leading cause of death for CF patients and inhaled tobramycin is the first-in-line antibiotic treatment against these infections, mainly caused by Pseudomonas aeruginosa in adult patients.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!